tirzepatide versus zepbound vs Ozempic Zepbound Versus Wegovy: Head-to-Head Trial

Apparent differences smaller than 2-fold may not be biologically meaningful

Reconstitution behavior can vary subtly

Current clinical evidence does not demonstrate that Ozempic causes thyroid problems in humans

Tirzepatide has demonstrated superior efficacy in both weight loss and blood glucose control compared to semaglutide (Aronne et al., 2025), highlighting the therapeutic potential of multi-agonist strategies

Heres why, for now, healthcare providers generally advise against taking GLP-1s, including semaglutide, while breastfeeding: Milk supply: The early postpartum period is when your body is building its milk supply